Just quickly: Should have read towards the end:PURCHASED...

First 3556 Last

Share
Profile

Follow
Wasabibarako

13,027 Posts.

783

05/11/21

22:07

Post #: 57360515
Share

Originally posted by Wasabibarako: ↑

It is Friday night and I reply to myself - because I would like to 'elaborate' a bit MORE on that article I did mention in my post this afternoon. Please realise that I am NOT a professional translator but I do try my BEST to correctly translate further parts of that article of today as follows:

Please NOTE, that highlighting by using BIG LETTERS is done by me and NOT in the orginal article !

Here goes:

When fully cashed-up, Norvartis' boss Vas Narasimhan is planning for a special type of "liberation blow". The BILLIONS available he does not plan to invest into the purchase of another PHARMA GIANT. Instead, investments into the purchase of several companies with promise will be made. The independent pharma analyst Michel Nawrath states: "There are NO big and still "purchaseable" companies around that are really good/promising in the field of the aimed at NEW TECHNOLOGIES.

The focus of the "NEW" NOVARTIS will be primarily into the following THERAPIES: Gen / Cell / RADIOLIGAND, which are mainly being developed by smaller American companies. Novartis - by acquiring companies in these areas of new forms of therapies - will further stimulate that field.
Quite a few of Novartis' patents will expire before much longer and from Novartis' own developments, little new supply can be expected.
The main issue/aim for the pharma industry (both in own research as well as in the area of acquiring companies) are no longer single medications but instead TECHNOLOGY-PLATFORMS, which can be used immediately against a number of diseases.

In this field, Novartis is already present. This, however, ONLY due to the fact of company purchases in the past few years. "To enter new technologies rapidly based upon own internal research strength alone is simply not possible for ANY BIG PHARMA company", mentions Nawrath.

Thereafter a table showing: "The biggest purchases done by NOVARTIS' Narasimhan":

Purchase Company Year Price (always in bio.) Indication

The Medicines Company 2020 9.7 Too high cholesterol level
Xiidra 2019 3.4 Dry eyes
Endocyte 2018 2.1 Prostate cancer
AveXis 2018 8.7 Spinal muscular atrophy
Advanced Accelerator App. 2018 3.9 Cancer (neuroendocrine)

----------------------------------------------------------------------------------------------------------------------------

I promised in the past NOT to post again until the IMU share-price would be above 50 cents!! Of course,
I did break my promise and did post a few times regardless - sorry about that.
But now, I am very pleased that the share-price level has not just gone over the 50c mark but is in
fact NEARING 60 cents. How pleasing is that on a FRIDAY NIGHT ?!

Wishing all IMU holders and buyers a relaxing weekend ahead. Stay safe, stay healthy - be happy!

wasa

Expand

Just quickly: Should have read towards the end:

PURCHASED company: The Medicines Company
Year: 2020
Amount in bio: 9.7
Indication: Too high cholesterol level
etc. etc.
You get the drift....

wasa

IMU Price at posting: 59.0¢ Sentiment: Buy Disclosure: Held
11 Upvote

0 Great analysis

Reply

Top Stories

MIN

MinRes board pushes back on Ellison tax dodge claims – but notes 'regret'

ION

Iondrive battery recovery achieves strong critical minerals recovery from black mass

HRE

Deal between Heavy Rare Earths and Havilah hands former SA uranium assets

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

M2M

M2M pours gold bar, finds 458.39g/t assay through bulk sampling at Golden Crown

There are more pages in this discussion • 12,290 more messages in this thread...

First 3556 Last

Add IMU (ASX) to my watchlist

(20min delay)
Last 4.9¢		Change 0.000(0.00%)		Mkt cap ! $364.4M

Open	High	Low	Value	Volume
4.9¢	5.0¢	4.9¢	$15.99K	325.6K

Buyers (Bids)

No.	Vol.	Price($)
31	3887106	4.9¢

Sellers (Offers)

Price($)	Vol.	No.
5.0¢	2519521	18

View Market Depth

No.	Vol.	Price($)
20	3075363	0.049
95	13038145	0.048
58	6515985	0.047
30	3952036	0.046
51	4977166	0.045

Price($)	Vol.	No.
0.050	149299	2
0.051	1149798	7
0.052	1191692	8
0.053	1765338	11
0.054	2857321	12

Last trade - 10.15am 21/10/2024 (20 minute delay)

IMU (ASX) Chart

Just quickly: Should have read towards the end:PURCHASED...

MinRes board pushes back on Ellison tax dodge claims – but notes 'regret'

Iondrive battery recovery achieves strong critical minerals recovery from black mass

Deal between Heavy Rare Earths and Havilah hands former SA uranium assets

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

M2M pours gold bar, finds 458.39g/t assay through bulk sampling at Golden Crown

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Just quickly: Should have read towards the end:PURCHASED...

Top Stories

MinRes board pushes back on Ellison tax dodge claims – but notes 'regret'

Iondrive battery recovery achieves strong critical minerals recovery from black mass

Deal between Heavy Rare Earths and Havilah hands former SA uranium assets

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

M2M pours gold bar, finds 458.39g/t assay through bulk sampling at Golden Crown

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News